PETS · NASDAQ
PetMed Express, Inc.
$1.18 +0.01 (+0.85%)
Company overview
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies, as well as prescription medications including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, along with generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Exchange
- NASDAQ
- Market cap
- $25.6M
- Employees
- 287
- Headquarters
- Delray Beach, FL
- Website
- 1800petmeds.com
- CEO
- Leslie C. G. Campbell
- Listed
- April 26, 1999
- P/E
- -0.43
- Dividend yield
- 9.40%
Company financials
- Revenue
- $179M
- Gross profit
- $50.2M
- Operating income
- -$58.7M
- EBITDA
- -$46.1M
- Net income
- -$57.3M
- EPS
- -$2.75
- Total assets
- $81.2M
- Total debt
- $535,000
- Gross margin
- 28.05%
- Net margin
- -32.00%
- Earnings yield
- -233.05%
No geographic segmentation.
Showing FY 2026
PETS
1D
NASDAQ
O1.22H1.22L1.15C1.16-0.06 (-4.92%)Vol94.93K